Cargando…
Bone Marrow-Derived NCS-01 Cells Advance a Novel Cell-Based Therapy for Stroke
Human mesenchymal stem cells have been explored for their application in cell-based therapies targeting stroke. Identifying cell lines that stand as safe, accessible, and effective for transplantation, while optimizing dosage, timing, and method of delivery remain critical translational steps toward...
Autores principales: | Brown, John, Park, You Jeong, Lee, Jea-Young, Chase, Thomas N., Koga, Minako, Borlongan, Cesar V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215343/ https://www.ncbi.nlm.nih.gov/pubmed/32325813 http://dx.doi.org/10.3390/ijms21082845 |
Ejemplares similares
-
Bone marrow-derived NCS-01 cells for ischemic stroke
por: Saft, Madeline, et al.
Publicado: (2021) -
Translating intracarotid artery transplantation of bone marrow‐derived NCS‐01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into stem cell therapy
por: Kaneko, Yuji, et al.
Publicado: (2019) -
Stroke gets in your eyes: stroke-induced retinal ischemia and the potential of stem cell therapy
por: Kingsbury, Chase, et al.
Publicado: (2019) -
A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells
por: Glover, Loren E., et al.
Publicado: (2011) -
Neuroprotective effects of human bone marrow mesenchymal stem cells against cerebral ischemia are mediated in part by an anti-apoptotic mechanism
por: Zhang, Yuyang, et al.
Publicado: (2019)